-
公开(公告)号:US20060084640A1
公开(公告)日:2006-04-20
申请号:US11251445
申请日:2005-10-14
申请人: Vijay Gore , Vu Ma , Mark Norman , Vassil Ognyanov , Ning Xi
发明人: Vijay Gore , Vu Ma , Mark Norman , Vassil Ognyanov , Ning Xi
IPC分类号: A61K31/551 , A61K31/496 , A61K31/454 , A61K31/4439 , C07D403/02
CPC分类号: C07D233/64 , C07D401/12
摘要: Therapeutic benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
摘要翻译: 治疗性苯并咪唑和含有它们的组合物,用于治疗急性,炎性和神经性疼痛,牙痛,一般头痛,偏头痛,丛集性头痛,混合血管和非血管综合征,紧张性头痛,一般炎症,关节炎,风湿性疾病,骨关节炎 ,炎症性肠病,炎症性眼病,炎症性或不稳定性膀胱病,银屑病,皮肤炎症成分炎症,慢性炎性病症,炎性疼痛及相关的痛觉过敏和异常性疼痛,神经性疼痛及相关的痛觉过敏和异常性疼痛,糖尿病性神经病疼痛,灼痛,交感神经痛 维持疼痛,输血综合征,哮喘,上皮组织损伤或功能障碍,单纯疱疹,呼吸道,泌尿生殖道,胃肠道或血管区内脏运动紊乱,伤口,烧伤,过敏性皮肤反应,瘙痒,白癜风,一般胃肠道疾病,胃溃疡 十二指肠溃疡,腹泻,坏死因子诱导的胃损伤,毛发生长,血管舒缩或过敏性鼻炎,支气管疾病或膀胱疾病。
-
公开(公告)号:US20070265248A1
公开(公告)日:2007-11-15
申请号:US11116759
申请日:2005-04-27
申请人: Christopher Fotsch , Premilla Arasasingham , Yunxin Bo , Ning Chen , Martin Goldberg , Nianhe Han , Feng-Yin Hsieh , Michael Kelly , Qingyian Liu , Mark Norman , Duncan Smith , Markian Stec , Nuria Tamayo , Ning Xi , Shimin Xu , Elizabeth Doherty
发明人: Christopher Fotsch , Premilla Arasasingham , Yunxin Bo , Ning Chen , Martin Goldberg , Nianhe Han , Feng-Yin Hsieh , Michael Kelly , Qingyian Liu , Mark Norman , Duncan Smith , Markian Stec , Nuria Tamayo , Ning Xi , Shimin Xu , Elizabeth Doherty
IPC分类号: A61K31/4965 , A61K31/497 , A61K31/551 , A61P3/10 , C07D243/08 , C07D401/00 , C07D403/12 , C07D407/00
CPC分类号: C07D207/08 , A61K38/00 , C07D205/04 , C07D207/09 , C07D209/14 , C07D209/42 , C07D211/26 , C07D211/60 , C07D211/62 , C07D213/38 , C07D213/81 , C07D213/82 , C07D215/48 , C07D217/06 , C07D217/14 , C07D217/26 , C07D233/64 , C07D295/185 , C07D317/60 , C07D317/68 , C07D319/18 , C07D401/12 , C07D403/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D451/02 , C07K5/06026 , C07K5/06139 , C07K5/06147 , C07K5/06191
摘要: Selected substituted piperazine compounds are effective for prophylaxis and treatment of diseases, such as obesity and the like. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving activation of the melanocortin receptor. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选的取代哌嗪化合物对于预防和治疗诸如肥胖症等疾病是有效的。 本发明包括新颖的化合物,类似物,前药和药学上可接受的盐,用于预防和治疗涉及黑皮质素受体活化的疾病和其它疾病或病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US20160229837A1
公开(公告)日:2016-08-11
申请号:US14880199
申请日:2015-10-10
申请人: Ning Xi , Minxiong Li , Xiaobo Li , Weilong Dai , Haiyang Hu , Tao Zhang , Wuhong Chen
发明人: Ning Xi , Minxiong Li , Xiaobo Li , Weilong Dai , Haiyang Hu , Tao Zhang , Wuhong Chen
IPC分类号: C07D401/14 , A61K45/06 , A61K31/506
CPC分类号: C07D401/14 , A61K31/506 , A61K45/06
摘要: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要翻译: 本发明提供了用于预防,控制,治疗或减轻蛋白激酶介导的疾病的严重性的新颖的杂芳基化合物,其药学上可接受的盐和制剂。 本发明还提供包含这些化合物的药学上可接受的组合物和使用该组合物治疗蛋白激酶介导的疾病的方法。
-
公开(公告)号:US20150274704A1
公开(公告)日:2015-10-01
申请号:US14670421
申请日:2015-03-27
申请人: Ning Xi , Minxiong Li , Haiyang Hu , Weilong Dai
发明人: Ning Xi , Minxiong Li , Haiyang Hu , Weilong Dai
IPC分类号: C07D403/14 , A61K45/06 , C07D401/14 , A61K31/527 , A61K31/506
CPC分类号: C07D403/14 , A61K31/506 , A61K31/527 , A61K45/06 , C07D401/14 , C07D403/12 , C07D493/04
摘要: The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
摘要翻译: 本发明提供了用于预防,治疗或减轻蛋白激酶介导的疾病的严重性的新颖的杂芳基化合物,其药学上可接受的盐和制剂。 本发明还提供包含这些化合物的药学上可接受的组合物和使用该组合物治疗蛋白激酶介导的疾病的方法。
-
公开(公告)号:US20150087658A1
公开(公告)日:2015-03-26
申请号:US14488296
申请日:2014-09-17
申请人: Ning Xi , Liang Wang , Tingjin Wang
发明人: Ning Xi , Liang Wang , Tingjin Wang
IPC分类号: C07D413/14 , C07D401/14
CPC分类号: C07D413/14 , A61K31/506 , A61K31/517 , A61K45/06 , C07D401/14 , C07D403/14 , C07D417/14 , Y02A50/409 , A61K2300/00
摘要: The invention relates to the preparation and use of new aminopyrimidine derivatives as drug candidates in free form or in pharmaceutically acceptable salt form and formulations thereof for the modulation of a disorder or disease which is mediated by the activity of the PI3K enzymes. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of disorders or diseases, such as disorders of immunity and inflammation in which PI3K enzymes play a role in leukocyte function, and hyperproliferative disorders associated with PI3K activity, including but not restricted to leukemias and solid tumors, in mammals, especially humans.
摘要翻译: 本发明涉及新的氨基嘧啶衍生物作为游离形式的候选药物或其药学上可接受的盐形式及其制剂用于调节由PI3K酶的活性介导的病症或疾病的制备和用途。 本发明还提供包含这些化合物的药学上可接受的组合物和使用该组合物治疗疾病或疾病的方法,例如PI3K酶在白细胞功能中起作用的免疫和炎症紊乱,以及与PI3K活性相关的过度增生性疾病, 包括但不限于白血病和实体瘤,哺乳动物,特别是人类。
-
公开(公告)号:US08642624B2
公开(公告)日:2014-02-04
申请号:US13297213
申请日:2011-11-15
申请人: Guoqing Chen , Jeffrey A. Adams , Jean E. Bemis , Shon Booker , Guolin Cai , Lucian V. DiPietro , Celia Dominguez , Daniel Elbaum , Julie Germain , Stephanie Geuns-Meyer , Michael K. Handley , Qi Huang , Joseph L. Kim , Tae-Seong Kim , Alexander S. Kiselyov , Xiaohu Ouyang , Vinod F. Patel , Leon M. Smith , Markian M. Stec , Andrew Tasker , Ning Xi , Shimin Xu , Chester Chenguang Yuan , Michael D. Croghan
发明人: Guoqing Chen , Jeffrey A. Adams , Jean E. Bemis , Shon Booker , Guolin Cai , Lucian V. DiPietro , Celia Dominguez , Daniel Elbaum , Julie Germain , Stephanie Geuns-Meyer , Michael K. Handley , Qi Huang , Joseph L. Kim , Tae-Seong Kim , Alexander S. Kiselyov , Xiaohu Ouyang , Vinod F. Patel , Leon M. Smith , Markian M. Stec , Andrew Tasker , Ning Xi , Shimin Xu , Chester Chenguang Yuan , Michael D. Croghan
IPC分类号: A01N43/40 , A61K31/44 , A01N43/38 , A61K31/40 , A61K31/405
CPC分类号: C07D213/82 , A61K31/443 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/4725 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/538 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/00 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04
摘要: Selected heterocyclic compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like.
摘要翻译: 所选择的杂环化合物对于预防和治疗诸如血管生成介导的疾病等疾病是有效的。 本发明包括新型化合物,类似物,前药及其药学上可接受的衍生物,用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。
-
公开(公告)号:US07652009B2
公开(公告)日:2010-01-26
申请号:US11289659
申请日:2005-11-29
申请人: Tae-Seong Kim , Steven Bellon , Shon Booker , Noel D'Angelo , Celia Dominguez , Ingrid Fellows , Matthew Lee , Longbin Liu , Elizabeth Rainbeau , Aaron C. Siegmund , Andrew Tasker , Ning Xi , Yuan Cheng
发明人: Tae-Seong Kim , Steven Bellon , Shon Booker , Noel D'Angelo , Celia Dominguez , Ingrid Fellows , Matthew Lee , Longbin Liu , Elizabeth Rainbeau , Aaron C. Siegmund , Andrew Tasker , Ning Xi , Yuan Cheng
IPC分类号: A61K31/506 , C07D401/02 , C07D239/22
CPC分类号: C07D401/14 , C07D215/233 , C07D401/12 , C07D409/14 , C07D413/12
摘要: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选化合物对于预防和治疗诸如HGF介导的疾病等疾病是有效的。 本发明包括新颖的化合物,类似物,前药和药学上可接受的盐,用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US20090217508A1
公开(公告)日:2009-09-03
申请号:US11989036
申请日:2006-07-21
申请人: Ning Xi , Uchechukwu Wejinya , Yantao Shen
发明人: Ning Xi , Uchechukwu Wejinya , Yantao Shen
CPC分类号: B81C99/002 , Y10S977/872 , Y10T29/49998 , Y10T29/53991
摘要: An end-effector is provided for use on a micro/nano manipulation device. The end-effector is comprised of: a micropump fluidly coupled to a microtube; a piezoelectric sensing structure disposed in the microtube; and a processing circuit electrically coupled to the sensing structure for determining the force of the fluid flowing through the microtube. The end-effector is a closed loop control-enabled micro/nano manipulation system.
摘要翻译: 提供用于微/纳米操纵装置的末端执行器。 末端执行器包括:流体耦合到微管的微型泵; 设置在微管中的压电感测结构; 以及电耦合到感测结构以用于确定流过微管的流体的力的处理电路。 末端执行器是一个闭环控制的微/纳米操纵系统。
-
公开(公告)号:US20090143575A1
公开(公告)日:2009-06-04
申请号:US12367352
申请日:2009-02-06
申请人: Chenera Balan , Yunxin Bo , Celia Dominguez , Christopher H. Fotsch , Vijay K. Gore , Vu Van Ma , Mark H. Norman , Vassil I. Ognyanov , Yi-xin Qian , Xianghong Wang , Ning Xi , Shimin Xu
发明人: Chenera Balan , Yunxin Bo , Celia Dominguez , Christopher H. Fotsch , Vijay K. Gore , Vu Van Ma , Mark H. Norman , Vassil I. Ognyanov , Yi-xin Qian , Xianghong Wang , Ning Xi , Shimin Xu
IPC分类号: C07D413/14 , C07D471/04 , C07D401/14
CPC分类号: C07D401/04 , C07D235/30 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Therapeutic benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotizing agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
摘要翻译: 治疗性苯并咪唑和含有它们的组合物,用于治疗急性,炎性和神经性疼痛,牙痛,一般头痛,偏头痛,丛集性头痛,混合血管和非血管综合征,紧张性头痛,一般炎症,关节炎,风湿性疾病,骨关节炎 ,炎症性肠病,炎症性眼病,炎症性或不稳定性膀胱病,银屑病,皮肤炎症成分炎症,慢性炎性病症,炎性疼痛及相关的痛觉过敏和异常性疼痛,神经性疼痛及相关的痛觉过敏和异常性疼痛,糖尿病性神经病疼痛,灼痛,交感神经痛 维持疼痛,输血综合征,哮喘,上皮组织损伤或功能障碍,单纯疱疹,呼吸道,泌尿生殖道,胃肠道或血管区内脏运动紊乱,伤口,烧伤,过敏性皮肤反应,瘙痒,白癜风,一般胃肠道疾病,胃溃疡 十二指肠溃疡,腹泻,坏死因子诱发的胃损伤,毛发生长,血管舒缩或过敏性鼻炎,支气管疾病或膀胱疾病。
-
公开(公告)号:US07524873B2
公开(公告)日:2009-04-28
申请号:US11700336
申请日:2007-01-30
申请人: Michael G. Kelly , Shimin Xu , Ning Xi , Philip Miller , John F. Kincaid , Chiara Ghiron , Thomas S. Coulter
发明人: Michael G. Kelly , Shimin Xu , Ning Xi , Philip Miller , John F. Kincaid , Chiara Ghiron , Thomas S. Coulter
IPC分类号: A61K31/4439 , C07D401/12
CPC分类号: C07C233/36 , C07C211/27 , C07C211/29 , C07C211/30 , C07C211/55 , C07C215/46 , C07C217/54 , C07C217/58 , C07C229/38 , C07C233/43 , C07C233/46 , C07C235/20 , C07C237/30 , C07C255/58 , C07C255/59 , C07C275/40 , C07C311/08 , C07C317/32 , C07C2601/02 , C07D207/26 , C07D207/27 , C07D207/325 , C07D209/08 , C07D209/10 , C07D209/44 , C07D211/22 , C07D211/70 , C07D213/26 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/64 , C07D213/65 , C07D213/68 , C07D213/73 , C07D213/75 , C07D213/82 , C07D215/12 , C07D215/14 , C07D231/56 , C07D233/22 , C07D235/06 , C07D235/10 , C07D235/12 , C07D237/08 , C07D237/14 , C07D239/26 , C07D239/34 , C07D239/42 , C07D241/12 , C07D241/42 , C07D249/18 , C07D261/08 , C07D263/32 , C07D263/56 , C07D271/06 , C07D271/08 , C07D271/10 , C07D271/12 , C07D277/24 , C07D277/28 , C07D277/40 , C07D277/42 , C07D277/66 , C07D285/01 , C07D295/096 , C07D295/135 , C07D295/185 , C07D295/26 , C07D307/42 , C07D307/52 , C07D307/68 , C07D317/46 , C07D317/54 , C07D319/18 , C07D321/10 , C07D333/16 , C07D333/20 , C07D333/56 , C07D401/12 , C07D405/12 , C07D471/04 , C07D487/04
摘要: The compounds of the invention are represented by the following general structure or a pharmaceutically acceptable salt thereof, and compositions containing them, wherein the variables are defined herein, and their use to reduce or inhibit PTH secretion, including methods for reducing or inhibiting PTH secretion and methods for treatment or prophylaxis of diseases associated with bone disorders, such as osteoporosis, or associated with excessive secretion of PTH, such as hyperparathyroidism. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 本发明的化合物由以下一般结构或其药学上可接受的盐以及含有它们的组合物表示,其中变量在本文中定义,及其用于减少或抑制PTH分泌的用途,包括减少或抑制PTH分泌的方法,以及 用于治疗或预防与骨疾病相关的疾病如骨质疏松症或与过度分泌的PTH相关的疾病如甲状旁腺功能亢进的方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
-
-
-
-
-
-
-
-